• Science & Technology

The long road to targeting the holy grail of the immune response

A team of our scientists at University College London have developed a potential new immunotherapy drug and caused another paradigm shift in our understanding of how cancer immunotherapy works. A team of our scientists at University College London have developed a potential new immunotherapy drug and caused another paradigm shift in our understanding of how cancer immunotherapy works.

9 November 2020

• Health & Medicine

What's happened to cancer clinical trials during the COVID-19 pandemic?

As coronavirus cases continue to rise in the UK, we look at how cancer clinical trials have been affected by the pandemic. As coronavirus cases continue to rise in the UK, we look at how cancer clinical trials have been affected by the pandemic.

4 November 2020

• Science & Technology

We’re asking scientists to tackle 9 of the toughest challenges in cancer research

We’ve partnered with the National Cancer Institute in the US (NCI) to stimulate even more innovative research collaborations through Cancer Grand Challenges. We’ve partnered with the National Cancer Institute in the US (NCI) to stimulate even more innovative research collaborations through Cancer Grand Challenges.

14 October 2020

• Science & Technology

The team of over 60 scientists investigating the age-old mystery of inflammation and cancer

We spoke to 3 members of the global STORMing Cancer team about their work to solve the mystery of inflammation and cancer. We spoke to 3 members of the global STORMing Cancer team about their work to solve the mystery of inflammation and cancer.

24 September 2020

• Health & Medicine

The changing landscape of children's cancer treatment

We spoke to Professor Lou Chesler and Dr Lynley Marshall about the innovative studies that are aiming to make children's cancer treatment more tailored. We spoke to Professor Lou Chesler and Dr Lynley Marshall about the innovative studies that are aiming to make children's cancer treatment more tailored.

2 September 2020

• Health & Medicine

The team tackling the serious side effects of cancer treatment in an ageing population

We spoke to the team looking into the complex relationship between the gut microbiome and radiosensitisation in bladder cancer. We spoke to the team looking into the complex relationship between the gut microbiome and radiosensitisation in bladder cancer.

19 August 2020

• Science & Technology

COVID-19: “We've got so much on our plates”

We caught up with two of our researchers about how COVID-19 has impacted their work, and what the next few months looks like for them. We caught up with two of our researchers about how COVID-19 has impacted their work, and what the next few months looks like for them.

4 August 2020

• Science & Technology

Cytosponge: A ‘sponge on a string' test to detect oesophageal cancer earlier

Looking at the latest results from the BEST3 trial, analysing the ‘sponge-on-a-string' test to detect oesophageal cancer earlier. Looking at the latest results from the BEST3 trial, analysing the ‘sponge-on-a-string' test to detect oesophageal cancer earlier.

31 July 2020

• Policy & Insight

COVID-19: “We’re having to rebuild and adapt because of coronavirus”

We’re having to scale down our work to reflect our new situation, but our ambition remains the same, writes our chief executive, Michelle Mitchell. We’re having to scale down our work to reflect our new situation, but our ambition remains the same, writes our chief executive, Michelle Mitchell.

15 July 2020

• Health & Medicine

Pursuing precision medicine in a flagship lung cancer trial

The National Lung Matrix Trial - a £25 million collaboration with pharmaceutical companies and the NHS - has been exploring how patients with non small cell lung cancer respond to more tailored, targeted treatments. The National Lung Matrix Trial - a £25 million collaboration with pharmaceutical companies and the NHS - has been exploring how patients with non small cell lung cancer respond to more tailored, targeted treatments.

15 July 2020

• Health & Medicine

COVID-19: “The really hard part is we know what needs to be done”

We caught up with a number of researchers about how COVID-19 has impacted their work, and what the next few months looks like for them. We caught up with a number of researchers about how COVID-19 has impacted their work, and what the next few months looks like for them.

7 July 2020

• Science & Technology
• Health & Medicine

COVID-19: “It could take months to build research up again”

Professor Richard Gilbertson talks about the impact of COVID-19 on research at the Cancer Research UK Cambridge Centre. Professor Richard Gilbertson talks about the impact of COVID-19 on research at the Cancer Research UK Cambridge Centre.

1 July 2020